 InVivo Therapeutics Holdings Corp. NVIV today announced the closing of its previously announced registered direct offering priced at-the-market under Nasdaq rules of 1,715,240 shares of its common stock at a purchase price of 1.75 per share. The Company also issued to the purchasers of such shares unregistered warrants to purchase up to 1,715,240 shares of common stock. The warrants have an exercise price of 1.62 per share, are exercisable immediately, and will expire five and one-half years from the date of issuance. 